OmniTier customers keep control and retain ownership of their genomics data
(BAY AREA, CA, USA November 9th, 2021) In response to requirements from some competing human genomics analysis providers to allow them certain usage rights over the customer’s data, OmniTier announces that customers using its secondary analysis and variant interpretation appliances, CompStor Novos® and CompStor Insight® keep full control and ownership of all their data.
Mitochondrial DNA analysis is added to OmniTier’s CompStor® family of genomics secondary and tertiary analysis appliances
(SAN JOSE, CA, USA – March 1st, 2021) OmniTier announced today that its CompStor® family now supports mitochondrial analysis in both its secondary and tertiary analysis appliances. Accurate identification of the mitochondrial genome are key requirements for researchers and clinicians seeking to improve their understanding of mitochondrial dysfunction.